Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
Molecular Therapy Oncolytics|December 3, 2019
High-Affinity DARPin Allows Targeting of MeV to Glioblastoma Multiforme in Combination with Protease Targeting without Loss of PotencyJan R H Hanauer, Vivian Koch, Ulrich M Lauer, et al.Journal of Virology|November 16, 2018
A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy ModelCindy Nürnberger, Bianca S Bodmer, Anna H Fiedler, et al.The Journal of Gene Medicine|May 5, 2010
Functional HIV-2- and SIVsmmPBj- derived lentiviral vectors generated by a novel polymerase chain reaction-based approachBjörn-Philipp Kloke, Silke Schüle, Michael D Mühlebach, et al.The Journal of General Virology|March 3, 2004
Genetic engineering of onco/lentivirus hybrids results in formation of infectious but not of replication-competent virusesStefanie Steidl, Silke Schüle, Michael D Mühlebach, et al.Virology|June 15, 2018
Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse modelBianca S Bodmer, Anna H Fiedler, Jan R H Hanauer, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2005
Stable transduction of primary human monocytes by simian lentiviral vector PBjMichael D Mühlebach, Nina Wolfrum, Silke Schüle, et al.Journal of Molecular Medicine (Berlin, Germany)|October 25, 2003
Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytesMichael D Mühlebach, Isabel Schmitt, Stefanie Steidl, et al.Virology|April 10, 2007
Impact of viral accessory proteins of SIVsmmPBj on early steps of infection of quiescent cellsNina Wolfrum, Michael D Mühlebach, Silke Schüle, et al.The Journal of General Virology|April 8, 2021
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infectionLisa Henss, Arne Auste, Christoph Schürmann, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 26, 2008
Targeted cell entry of lentiviral vectorsSabrina Funke, Andrea Maisner, Michael D Mühlebach, et al.Pageof 5